The 4,000 Shares of Silicon Laboratories Inc. (SLAB) Stock are sold by Jack R. Lazar

The 4,000 Shares of Silicon Laboratories Inc. (SLAB) Stock are sold by Jack R. Lazar

Silicon Laboratories Inc. (NASDAQ:SLAB) Director Jack R. Lazar sold 4,000 shares of the business’s stock in a transaction on Wednesday, October 5th. The shares were sold at an average price of $60.00, for a total value of $240,000.00. Following the completion of the sale, the director now directly owns 13,324 shares in the company, valued at approximately $799,440. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Silicon Laboratories Inc. (NASDAQ:SLAB) opened at 59.46 on Friday. The stock’s 50 day moving average price is $56.85 and its 200 day moving average price is $50.60. The firm has a market cap of $2.47 billion, a price-to-earnings ratio of 67.57 and a beta of 1.42. Silicon Laboratories Inc. has a 52 week low of $36.56 and a 52 week high of $60.00.

Silicon Laboratories (NASDAQ:SLAB) last posted its quarterly earnings data on Wednesday, July 27th. The company reported $0.75 EPS for the quarter, topping the Zacks’ consensus estimate of $0.64 by $0.11. Silicon Laboratories had a return on equity of 8.71% and a net margin of 5.66%. The firm had revenue of $174.90 million for the quarter, compared to analyst estimates of $170.52 million. During the same quarter last year, the company earned $0.56 EPS. The company’s revenue was up 6.1% on a year-over-year basis. On average, equities research analysts predict that Silicon Laboratories Inc. will post $2.54 EPS for the current year.

10/08/jack-r-lazar-sells-4000-shares-of-silicon-laboratories-inc-slab-stock.html

Institutional investors have recently bought and sold shares of the company. Bank of Montreal Can bought a new position in Silicon Laboratories during the second quarter worth approximately $132,000. Hermes Investment Management Ltd. raised its position in Silicon Laboratories by 18.2% in the second quarter. Hermes Investment Management Ltd. now owns 909,087 shares of the company’s stock worth $44,309,000 after buying an additional 140,260 shares during the period. LS Investment Advisors LLC raised its position in Silicon Laboratories by 74.3% in the second quarter. LS Investment Advisors LLC now owns 2,336 shares of the company’s stock worth $114,000 after buying an additional 996 shares during the period. BNP Paribas Arbitrage SA raised its position in Silicon Laboratories by 2,034.3% in the second quarter. BNP Paribas Arbitrage SA now owns 18,291 shares of the company’s stock worth $892,000 after buying an additional 17,434 shares during the period. Finally, Boothbay Fund Management LLC bought a new position in Silicon Laboratories during the first quarter worth approximately $298,000. Hedge funds and other institutional investors own 87.46% of the company’s stock.

Several analysts recently commented on the company. Needham & Company LLC reaffirmed a “hold” rating on shares of Silicon Laboratories in a research note on Wednesday. Stifel Nicolaus reaffirmed a “buy” rating and issued a $67.00 price target (up previously from $65.00) on shares of Silicon Laboratories in a research note on Friday, August 26th. Roth Capital initiated coverage on Silicon Laboratories in a research note on Wednesday, September 28th. They issued a “buy” rating and a $65.00 price objective on the stock. Zacks Investment Research lowered Silicon Laboratories from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, September 28th. Finally, Drexel Hamilton reissued a “buy” rating and issued a $52.00 price objective on shares of Silicon Laboratories in a research note on Thursday, July 28th. Six research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Silicon Laboratories has an average rating of “Buy” and a consensus price target of $57.91.

Silicon Laboratories Company Profile

Related posts

Leave a Comment